Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells

References

• Cairney CJ, Bilsland AE, Evans TR, Roffey J, Bennett DC, Narita M, Torrance CJ, Keith WN. 2012. Cancer cell senescence: a new frontier in drug development. Drug Dis Today. 17:269–276.
   PubMed Web of Science ®Google Scholar
• Campisi J. 2013. Aging, cellular senescence, and cancer. Ann Rev Physiol. 75:685–705.
   PubMed Web of Science ®Google Scholar
• Chen X, Song L, Hou Y, Li F. 2019. Reactive oxygen species induced by icaritin promote DNA strand breaks and apoptosis in human cervical cancer cells. Oncol Rep. 41:765–778.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. 2016. Cancer statistics in China, 2015. CA: a Cancer J Clin. 66:115–132.
   PubMed Web of Science ®Google Scholar
• Correia-Melo C, Marques FD, Anderson R, Hewitt G, Hewitt R, Cole J, Carroll BM, Miwa S, Birch J, Merz A, et al. 2016. Mitochondria are required for pro-ageing features of the senescent phenotype. Embo J. 35:724–742.
   PubMed Web of Science ®Google Scholar
• Deng Y, Chan SS, Chang S. 2008. Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer. 8:450–458.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. 2007. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 132:2557–2576.
   PubMed Web of Science ®Google Scholar
• Ewald JA, Desotelle JA, Wilding G, Jarrard DF. 2010. Therapy-induced senescence in cancer. J Nat Cancer Instit. 102:1536–1546.
   PubMed Web of Science ®Google Scholar
• Garinis GA, van der Horst GT, Vijg J, Hoeijmakers JH. 2008. DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol. 10:1241–1247.
   PubMed Web of Science ®Google Scholar
• Gonzale LC, Ghadaouia S, Martinez A, Rodier F. 2016. Premature aging/senescence in cancer cells facing therapy: good or bad? Biogerontology. 17:71–87.
   PubMed Web of Science ®Google Scholar
• Grimes A, Chandra SB. 2009. Significance of cellular senescence in aging and cancer. Cancer Res Treatment. 41:187–195.
   Google Scholar
• Guo Y, Zhang X, Meng J, Wang ZY. 2011. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. Eur J Pharmacol. 658:114–122.
   PubMed Web of Science ®Google Scholar
• Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P, Wyche JH. 2002. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem. 277:17154–17160.
   PubMed Web of Science ®Google Scholar
• He J, Wang Y, Duan F, Jiang H, Chen MF, Tang SY. 2010. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor. Planta Medica. 76:1834–1839.
   PubMed Web of Science ®Google Scholar
• Huang X, Zhu D, Lou Y. 2007. A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells. Eur J Pharmacol. 564:26–36.
   PubMed Web of Science ®Google Scholar
• Karpinich NO, Tafani M, Rothman RJ, Russo MA, Farber JL. 2002. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J Biol Chem. 277:16547–16552.
   PubMed Web of Science ®Google Scholar
• Kudryavtseva AV, Krasnov GS, Dmitriev AA, Alekseev BY, Kardymon OL, Sadritdinova AF, Fedorova MS, Pokrovsky AV, Melnikova NV, Kaprin AD, et al. 2016. Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget. 7:44879–44905.
   PubMed Web of Science ®Google Scholar
• Lee M, Lee JS. 2014. Exploiting tumor cell senescence in anticancer therapy. BMB Rep. 47:51–59.
   PubMed Web of Science ®Google Scholar
• Li C, Peng W, Song X, Wang Q, Wang W. 2016. Anticancer effect of icaritin inhibits cell growth of colon cancer through reactive oxygen species, Bcl-2 and cyclin D1/E signaling. Oncol Lett. 12:3537–3542.
   PubMed Web of Science ®Google Scholar
• Li S, Priceman SJ, Xin H, Zhang W, Deng J, Liu Y, Huang J, Zhu W, Chen M, Hu W, et al. 2013. Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma. PLoS One. 8:e81657.
   PubMed Web of Science ®Google Scholar
• Liu P, Jin X, Lv H, Li J, Xu W, Qian HH, Yin Z. 2014. Icaritin ameliorates carbon tetrachloride-induced acute liver injury mainly because of the antioxidative function through estrogen-like effects. In Vitro Cell Develop Biol Anim. 50:899–908.
   PubMed Web of Science ®Google Scholar
• Liu YQ, Wang SK, Xu QQ, Yuan HQ, Guo YX, Wang Q, Kong F, Lin ZM, Sun DQ, Wang RM, et al. 2019. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties. Acta Pharmacol Sinica. 40:689–698.
   PubMed Web of Science ®Google Scholar
• Rodier F, Campisi J. 2011. Four faces of cellular senescence. J Cell Biol. 192:547–556.
   PubMed Web of Science ®Google Scholar
• Sagiv A, Krizhanovsky V. 2013. Immunosurveillance of senescent cells: the bright side of the senescence program. Biogerontology. 14:617–628.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh PP, Roberts LR, Sanchez W. 2014. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 11:45–54.
   PubMed Web of Science ®Google Scholar
• Sun L, Peng Q, Qu L, Gong L, Si J. 2015. Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells. Mol Med Rep Med. 11:3094–3100.
   PubMed Web of Science ®Google Scholar
• Tong JS, Zhang QH, Huang X, Fu XQ, Qi ST, Wang YP, Hou Y, Sheng J, Sun QY. 2011. Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PLoS One. 6:e16781.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. 2015. Global cancer statistics, 2012. CA: Cancer J Clin. 65:87–108.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang X, Wang H, Qi L, Lou Y. 2007. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience. 145:911–922.
   PubMed Web of Science ®Google Scholar
• Wu J, Xu H, Wong PF, Xia S, Xu J, Dong J. 2014. Icaritin attenuates cigarette smoke-mediated oxidative stress in human lung epithelial cells via activation of PI3K-AKT and Nrf2 signaling. Food Chem Toxicol. 64:307–313.
   PubMed Web of Science ®Google Scholar
• Yao D, Xie X-H, Wang X-L, Wan C, Lee Y-W, Chen S-H, Pei D-Q, Wang Y-X, Li G, Qin L. 2012. Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis—an in vitro efficiency study. PLoS One. 7:e41264.
   PubMed Web of Science ®Google Scholar
• Zhang H. 2007. Molecular signaling and genetic pathways of senescence: its role in tumorigenesis and aging. J Cell Physiol. 210:567–574.
   PubMed Web of Science ®Google Scholar
• Zhang X, Ye C, Sun F, Wei W, Hu B, Wang J. 2016. Both complexity and location of DNA damage contribute to cellular senescence induced by ionizing radiation. PLoS One. 11:e0155725.
   PubMed Web of Science ®Google Scholar
• Zhu JF, Li ZJ, Zhang GS, Meng K, Kuang WY, Li J, Zhou XF, Li RJ, Peng HL, Dai CW, et al. 2011. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3/AKT signalings. PLoS One. 6:e23720.
   PubMed Web of Science ®Google Scholar
• Zhu DY, Lou YJ. 2005. Inducible effects of icariin, icaritin, and desmethylicaritin on directional differentiation of embryonic stem cells into cardiomyocytes in vitro. Acta Pharmacol Sinica. 26:477–485.
   PubMed Web of Science ®Google Scholar